| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
|
Ann Intern Med
|
2003
|
23.33
|
|
2
|
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.
|
N Engl J Med
|
2010
|
13.25
|
|
3
|
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
|
N Engl J Med
|
2011
|
7.42
|
|
4
|
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database.
|
Am J Kidney Dis
|
2007
|
5.06
|
|
5
|
Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.
|
Circulation
|
2011
|
4.95
|
|
6
|
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
|
Diabetes
|
2004
|
4.44
|
|
7
|
Nephropathy in diabetes.
|
Diabetes Care
|
2004
|
4.08
|
|
8
|
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.
|
Am J Kidney Dis
|
2010
|
3.87
|
|
9
|
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
|
Arch Intern Med
|
2011
|
3.20
|
|
10
|
Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes.
|
J Am Soc Nephrol
|
2006
|
3.12
|
|
11
|
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.
|
J Clin Endocrinol Metab
|
2010
|
2.70
|
|
12
|
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
|
Am J Kidney Dis
|
2003
|
2.68
|
|
13
|
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.
|
Arch Intern Med
|
2005
|
2.67
|
|
14
|
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.
|
Pediatr Diabetes
|
2005
|
2.64
|
|
15
|
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
|
Am J Hum Genet
|
2012
|
2.53
|
|
16
|
Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes.
|
PLoS One
|
2011
|
2.28
|
|
17
|
Racial differences in glycemic markers: a cross-sectional analysis of community-based data.
|
Ann Intern Med
|
2011
|
2.19
|
|
18
|
Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study.
|
Environ Health Perspect
|
2010
|
2.15
|
|
19
|
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.
|
Arch Intern Med
|
2008
|
2.01
|
|
20
|
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
|
Clin Chem
|
2012
|
2.00
|
|
21
|
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes.
|
Diabetes Care
|
2006
|
1.95
|
|
22
|
Study design for genetic analysis in the Jackson Heart Study.
|
Ethn Dis
|
2005
|
1.93
|
|
23
|
Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup.
|
Clin Chem
|
2007
|
1.88
|
|
24
|
Performance of A1C for the classification and prediction of diabetes.
|
Diabetes Care
|
2010
|
1.80
|
|
25
|
Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study.
|
J Diabetes
|
2010
|
1.77
|
|
26
|
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
|
Am J Kidney Dis
|
2010
|
1.71
|
|
27
|
Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care.
|
Diabetes Care
|
2010
|
1.69
|
|
28
|
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.
|
Diabetes
|
2007
|
1.65
|
|
29
|
HLA genotyping in the international Type 1 Diabetes Genetics Consortium.
|
Clin Trials
|
2010
|
1.61
|
|
30
|
Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.
|
J Am Soc Nephrol
|
2006
|
1.56
|
|
31
|
A prospective controlled study of kidney donors: baseline and 6-month follow-up.
|
Am J Kidney Dis
|
2013
|
1.55
|
|
32
|
Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes.
|
Diabetes
|
2010
|
1.53
|
|
33
|
Low serum adiponectin predicts future risk for asthma in women.
|
Am J Respir Crit Care Med
|
2012
|
1.52
|
|
34
|
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
|
Kidney Int
|
2002
|
1.48
|
|
35
|
HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study.
|
Diabetes Care
|
2006
|
1.48
|
|
36
|
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial.
|
Am J Kidney Dis
|
2009
|
1.45
|
|
37
|
Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium.
|
Clin Trials
|
2010
|
1.42
|
|
38
|
Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.
|
Diabetes
|
2013
|
1.37
|
|
39
|
Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study.
|
Clin Chem
|
2007
|
1.37
|
|
40
|
Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study.
|
Diabetes Care
|
2005
|
1.36
|
|
41
|
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories.
|
Clin Trials
|
2010
|
1.33
|
|
42
|
Nontraditional markers of glycemia: associations with microvascular conditions.
|
Diabetes Care
|
2011
|
1.32
|
|
43
|
Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
|
Am J Epidemiol
|
2006
|
1.28
|
|
44
|
Alternative markers of hyperglycemia and risk of diabetes.
|
Diabetes Care
|
2012
|
1.23
|
|
45
|
Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.
|
Diabetes
|
2003
|
1.20
|
|
46
|
Quality control of phenotypic forms data in the Type 1 Diabetes Genetics Consortium.
|
Clin Trials
|
2010
|
1.19
|
|
47
|
Toward standardization of insulin immunoassays.
|
Clin Chem
|
2009
|
1.17
|
|
48
|
Circulating carotenoid concentrations and incident hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
J Hypertens
|
2009
|
1.14
|
|
49
|
The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.
|
BMC Nephrol
|
2010
|
1.11
|
|
50
|
Circulating vitamin D metabolites and kidney disease in type 1 diabetes.
|
J Clin Endocrinol Metab
|
2012
|
1.11
|
|
51
|
Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study.
|
J Hypertens
|
2009
|
1.10
|
|
52
|
Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).
|
Am J Cardiol
|
2008
|
1.10
|
|
53
|
Determining stability of stored samples retrospectively: the validation of glycated albumin.
|
Clin Chem
|
2010
|
1.08
|
|
54
|
Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity.
|
Am J Kidney Dis
|
2006
|
1.07
|
|
55
|
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
|
Diabetes Care
|
2012
|
1.07
|
|
56
|
Factors associated with paraoxonase genotypes and activity in a diverse, young, healthy population: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
Clin Chem
|
2008
|
1.01
|
|
57
|
Fine-mapping in African Americans of 8 recently discovered genetic loci for plasma lipids: the Jackson Heart Study.
|
Circ Cardiovasc Genet
|
2010
|
1.00
|
|
58
|
Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.
|
J Am Soc Nephrol
|
2007
|
1.00
|
|
59
|
Inverse effects of the PPAR(gamma)2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study.
|
Metabolism
|
2005
|
1.00
|
|
60
|
Longitudinal changes in estimated and measured GFR in type 1 diabetes.
|
J Am Soc Nephrol
|
2013
|
0.98
|
|
61
|
Comparison of two assays for serum 1,5-anhydroglucitol.
|
Clin Chim Acta
|
2011
|
0.97
|
|
62
|
The association of cigarette smoking with self-reported disease before middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
Prev Med
|
2006
|
0.97
|
|
63
|
The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA study.
|
Clin Chem
|
2005
|
0.97
|
|
64
|
Relation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson Heart Study.
|
Circulation
|
2011
|
0.96
|
|
65
|
Differential associations of weight dynamics with coronary artery calcium versus common carotid artery intima-media thickness: The CARDIA Study.
|
Am J Epidemiol
|
2010
|
0.95
|
|
66
|
Obesity-asthma association: is it explained by systemic oxidant stress?
|
Chest
|
2009
|
0.94
|
|
67
|
Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
|
Clin J Am Soc Nephrol
|
2010
|
0.91
|
|
68
|
Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study.
|
Obesity (Silver Spring)
|
2010
|
0.91
|
|
69
|
Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes.
|
Diabetes Care
|
2013
|
0.88
|
|
70
|
Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study.
|
Atherosclerosis
|
2012
|
0.87
|
|
71
|
Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study.
|
J Mol Med (Berl)
|
2006
|
0.86
|
|
72
|
Association of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart Study.
|
Hypertension
|
2012
|
0.86
|
|
73
|
Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes.
|
Diabetes Care
|
2007
|
0.84
|
|
74
|
Dyslipidemia and the treatment of lipid disorders in African Americans.
|
Am J Med
|
2009
|
0.84
|
|
75
|
Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but Not in Women.
|
Front Pharmacol
|
2011
|
0.84
|
|
76
|
Measurement of circulating glucose concentrations: the time is now for consistency among methods and types of samples.
|
Clin Chem
|
2005
|
0.83
|
|
77
|
Is serum gamma-glutamyltransferase a biomarker of xenobiotics, which are conjugated by glutathione?
|
Arterioscler Thromb Vasc Biol
|
2008
|
0.82
|
|
78
|
Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients.
|
Nephron
|
2002
|
0.80
|
|
79
|
Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia.
|
Am J Kidney Dis
|
2010
|
0.78
|
|
80
|
Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis Risk in Communities (ARIC) study.
|
BMC Med Genet
|
2011
|
0.75
|
|
81
|
Estimating GFR from cystatin C in serum: seeking to enhance its clinical application.
|
Am J Kidney Dis
|
2006
|
0.75
|